Rislenemdaz

DB12063InvestigationalSmall molecule

Mk 0657 has been used in trials studying the treatment of Major Depressive Disorder.

Chemical structure of Rislenemdaz
Formula / weight
C19H23FN4O2 · 358.417 g/mol (avg)
Code names
CERC-301 · MK-0657

Resolves to

Compound
UNII5HAM167S5TCAS808732-98-1ChEMBLCHEMBL2068839PubChem11394238
Structure
InChIKeyRECBFDWSXWAXHY-IAGOWNOFSA-NSMILESCC1=CC=C(COC(=O)N2CC[C@H](CNC3=NC=CC=N3)[C@H](F)C2)C=C1
Targets
Q13224GRIN2B

What you can answer from here — as of October 28, 2025

1Protein targetEach mapped to UniProt, with action and pharmacological action
Listed above
3Clinical trialsPhase, status and sponsor resolved per trial
Sign in
1+ReferenceStructured and connected to the statements they support
Sign in

Which drugs share a target with Rislenemdaz, and which of those have an active Phase 3 trial?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In